Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention
Clinical trial NCT04760652 · COMPLETED
Trial details
- NCT number
- NCT04760652
- Sponsor
- Yale University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-05
- Primary completion
- 2025-06-30
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.